Sri Lanka's remarkable progress in extending life expectancy to nearly 78 years has created a new challenge: managing chronic diseases that now account for over 80% of deaths. Modern diagnostic tools and preventive technologies are transforming healthcare from reactive crisis management to proactive disease…
Sri Lanka's demographic transformation over the past century stands as a global achievement in public health. The expansion of free state-funded medical services, malaria eradication, and universal immunisation programmes reduced life expectancy from barely 50 years in the mid-twentieth century to approximately 78 years today—a figure that surpasses many South Asian neighbours and rivals developed nations. Women in Sri Lanka now routinely live past 79 years. However, this success has created an unforeseen consequence: the disease burden has fundamentally shifted from acute infectious illnesses to non-communicable diseases, which now cause over 80% of deaths nationwide.
The healthcare system's approach to managing these chronic conditions is undergoing a profound transformation. Rather than treating patients only after medical crises emerge—such as heart attacks or diabetic complications—modern diagnostic technologies now enable early detection of disease before symptoms appear. Continuous glucose monitors, advanced blood tests measuring insulin resistance, and affordable digital blood pressure devices allow individuals to track metabolic and cardiovascular health in real time. These tools have revolutionised management of conditions like type 2 diabetes and hypertension, shifting focus from crisis intervention to continuous, predictive risk management. Early detection of metabolic dysregulation can halt disease progression entirely, allowing intervention before organ damage occurs.
Simultaneously, minimally invasive surgical techniques have expanded treatment options for older adults. Advanced procedures such as transradial cardiac catheterization and transcatheter aortic valve replacement now allow complex procedures to be performed without major surgery, reducing recovery times and expanding who can safely receive treatment. The convergence of preventive diagnostics, wearable monitoring, modern pharmaceuticals, and innovative surgical approaches is fundamentally altering how aging itself is conceptualised—enabling individuals to preserve physical autonomy and cognitive function well into their seventies and eighties, a phenomenon known as compression of morbidity.
Yet significant equity concerns persist. Advanced monitoring devices, drug-eluting stents, and specialised interventional care remain expensive, accessible primarily to urban affluent populations. Rural and low-income citizens risk remaining vulnerable to unmanaged chronic disease despite these technological advances. Addressing this disparity requires integrating modern diagnostic tools into primary healthcare networks, leveraging mobile telecommunications infrastructure for telemedicine, and distributing subsidised monitoring devices to high-risk populations in agricultural and industrial regions. Sri Lanka's historical success in democratising basic healthcare must now extend to these preventive technologies to ensure that longer life expectancy translates to healthier life expectancy for all citizens.
